Likewise, Zhang H. et al. (2017) suggested that glioma patients from the CGGA, GSE4412, and TCGA datasets can be separated into high- and low-risk subclasses based upon levels of MAPK8IP1 and SH3GLB1 expression. The gene discussed is MAPK8IP1; the disease is central nervous system cancer.